Stephen Baxter
Stock Analyst at Wells Fargo
(3.19)
# 1,171
Out of 5,026 analysts
216
Total ratings
49.29%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Overweight | $5 → $1.5 | $1.02 | +47.06% | 9 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $267 → $400 | $361.15 | +10.76% | 15 | Oct 7, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $10 → $14 | $20.67 | -32.27% | 12 | Oct 7, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $198 → $231 | $192.39 | +20.07% | 20 | Oct 7, 2025 | |
| HUM Humana | Maintains: Overweight | $344 → $347 | $262.17 | +32.36% | 12 | Oct 7, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $330 → $412 | $349.49 | +17.89% | 13 | Oct 7, 2025 | |
| CI The Cigna Group | Maintains: Equal-Weight | $340 → $354 | $294.57 | +20.18% | 9 | Oct 7, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $30 → $41 | $35.79 | +14.56% | 23 | Oct 7, 2025 | |
| CVS CVS Health | Maintains: Overweight | $84 → $103 | $80.67 | +27.68% | 15 | Oct 7, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $210 → $249 | $205.00 | +21.46% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $238 | $199.23 | +19.46% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $375 → $412 | $420.25 | -1.96% | 16 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2.5 → $3 | $3.08 | -2.60% | 11 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $33 | $30.74 | +7.35% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $772 → $816 | $791.93 | +3.04% | 8 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $31 → $29 | $24.22 | +19.74% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $337 → $354 | $319.61 | +10.76% | 4 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $183 → $185 | $155.67 | +18.84% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $8.94 | +67.79% | 3 | Apr 29, 2024 |
agilon health
Oct 7, 2025
Maintains: Overweight
Price Target: $5 → $1.5
Current: $1.02
Upside: +47.06%
UnitedHealth Group
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $361.15
Upside: +10.76%
Oscar Health
Oct 7, 2025
Maintains: Underweight
Price Target: $10 → $14
Current: $20.67
Upside: -32.27%
Molina Healthcare
Oct 7, 2025
Maintains: Overweight
Price Target: $198 → $231
Current: $192.39
Upside: +20.07%
Humana
Oct 7, 2025
Maintains: Overweight
Price Target: $344 → $347
Current: $262.17
Upside: +32.36%
Elevance Health
Oct 7, 2025
Maintains: Overweight
Price Target: $330 → $412
Current: $349.49
Upside: +17.89%
The Cigna Group
Oct 7, 2025
Maintains: Equal-Weight
Price Target: $340 → $354
Current: $294.57
Upside: +20.18%
Centene
Oct 7, 2025
Maintains: Equal-Weight
Price Target: $30 → $41
Current: $35.79
Upside: +14.56%
CVS Health
Oct 7, 2025
Maintains: Overweight
Price Target: $84 → $103
Current: $80.67
Upside: +27.68%
Universal Health Services
Oct 7, 2025
Maintains: Overweight
Price Target: $210 → $249
Current: $205.00
Upside: +21.46%
Oct 7, 2025
Maintains: Overweight
Price Target: $200 → $238
Current: $199.23
Upside: +19.46%
Oct 7, 2025
Maintains: Equal-Weight
Price Target: $375 → $412
Current: $420.25
Upside: -1.96%
Oct 7, 2025
Maintains: Underweight
Price Target: $2.5 → $3
Current: $3.08
Upside: -2.60%
Oct 7, 2025
Maintains: Overweight
Price Target: $27 → $33
Current: $30.74
Upside: +7.35%
Sep 24, 2025
Maintains: Equal-Weight
Price Target: $772 → $816
Current: $791.93
Upside: +3.04%
Aug 14, 2025
Maintains: Equal-Weight
Price Target: $31 → $29
Current: $24.22
Upside: +19.74%
Aug 13, 2025
Maintains: Overweight
Price Target: $337 → $354
Current: $319.61
Upside: +10.76%
Aug 13, 2025
Maintains: Overweight
Price Target: $183 → $185
Current: $155.67
Upside: +18.84%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $8.94
Upside: +67.79%